Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Threonine tyrosine kinases are a class of protein kinases capable of phosphorylating both threonine and tyrosine residues on substrate proteins. This dual-specificity is relatively rare compared to the more common serine/threonine or tyrosine-only kinases. The most well-known example in this category is TTK, also known as monopolar spindle 1 (MPS1). These phosphorylation events regulate protein function, subcellular localization, interactions, and signal transduction pathways. TTK/MPS1 plays a critical role in cell cycle regulation by ensuring proper chromosome alignment during mitosis, making it a promising therapeutic target for various cancers.
ATP-dependent phosphate transfer; conformational change upon inhibitor binding; disruption of catalytic machinery
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Threonine Tyrosine Kinase.